"Ameliorating hypertension and insulin resistance: effects of ALCAR therapy." Hypertension 2009;54(3):567-74
GLP-1 medications primarily target fat reduction, not muscle breakdown
In contrast, NHAs, which have lower expression of DHHC9 compared to GBM cells, did not show significant alteration in glucose uptake or glycolytic rate when endogenous DHHC9 was depleted
Light-it designed and developed a custom platform that lets patients book and join virtual consultations, request prescriptions, and track their medication history, all while staying connected to care teams
Healthcare providers report increased pressure from patients who view GLP-1s as a quick fix rather than part of a comprehensive health strategy
Example: 2 mg 5 mg/mL = 0.4 mL injection volume daily